Company profile for Genfit

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two d...
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. Its most advanced drug candidate, elafibranor.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
Parc Eurasanté 885, Avenue Eugène Avinée 59120 Loos
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/10/3203416/0/en/GENFIT-GNS561-Shows-Promising-Antitumor-Activity-in-Combination-Therapy.html

GLOBENEWSWIRE
10 Dec 2025

https://www.globenewswire.com/news-release/2025/11/27/3195864/0/en/GENFIT-Announces-Appointment-of-new-Chief-Medical-Officer.html

GLOBENEWSWIRE
27 Nov 2025

https://www.globenewswire.com/news-release/2025/11/20/3192235/0/en/GENFIT-announces-effectiveness-of-voluntary-delisting-of-American-Depositary-Shares-from-Nasdaq-Stock-Market.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/20/3192243/0/en/GENFIT-Reports-Third-Quarter-2025-Financial-Information-and-Provides-a-Corporate-Update.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177871/0/en/GENFIT-announces-intention-to-voluntarily-delist-American-Depositary-Shares-from-The-Nasdaq-Global-Select-Market.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/28/3176028/0/en/GENFIT-Announces-Advances-Across-its-ACLF-Pipeline-at-AASLD-The-Liver-Meeting-2025.html

GLOBENEWSWIRE
28 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty